vorinostat has been researched along with Encephalopathy, Traumatic in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Also treatment with vorinostat ameliorates the altered expression of p-Akt, NF-B, iNOS and caspase by the western blot assay in the neuronal tissue of TBI mice and mRNA level of HO-1 and NQO-1 significantly enhanced in vorinostat compared to the negative control group." | 1.48 | Vorinostat: a histone deacetylases (HDAC) inhibitor ameliorates traumatic brain injury by inducing iNOS/Nrf2/ARE pathway. ( Shi, J; Xu, J; Zhang, J; Zhang, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T | 1 |
| Zhang, YM | 1 |
| Han, D | 1 |
| Hua, R | 1 |
| Guo, BN | 1 |
| Hu, SQ | 1 |
| Yan, XL | 1 |
| Xu, T | 1 |
| Xu, J | 1 |
| Shi, J | 1 |
| Zhang, J | 1 |
| Zhang, Y | 1 |
2 other studies available for vorinostat and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain Damage, Chronic; Brain Injuries, Traumatic; | 2017 |
Vorinostat: a histone deacetylases (HDAC) inhibitor ameliorates traumatic brain injury by inducing iNOS/Nrf2/ARE pathway.
Topics: Animals; Brain; Brain Injuries, Traumatic; Carboxylic Ester Hydrolases; Histone Deacetylase Inhibito | 2018 |